{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:23:44Z","timestamp":1777055024873,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":90,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["WI225911"],"award-info":[{"award-number":["WI225911"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1111\/jth.15552","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T07:02:40Z","timestamp":1633762960000},"page":"69-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6113-2694","authenticated-orcid":false,"given":"Alessio","family":"Branchini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6565-4943","authenticated-orcid":false,"given":"Massimo","family":"Morfini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1517-4762","authenticated-orcid":false,"given":"Barbara","family":"Lunghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donata","family":"Belvini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Radossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0333-0948","authenticated-orcid":false,"given":"Loredana","family":"Bury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Serino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7762-3500","authenticated-orcid":false,"given":"Paola","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorina","family":"Cultrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8078-8402","authenticated-orcid":false,"given":"Angelo Claudio","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8934-2936","authenticated-orcid":false,"given":"Mariasanta","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1892-4343","authenticated-orcid":false,"given":"Elisabetta","family":"Bigagli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4973-1317","authenticated-orcid":false,"given":"Giancarlo","family":"Castaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4114-7055","authenticated-orcid":false,"given":"Mirko","family":"Pinotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0305-2212","authenticated-orcid":false,"given":"Francesco","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Biasioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa Maria","family":"Caimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filomena","family":"Daniele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Dragani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donato","family":"Gemmati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Gresele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Linari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Sottilotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Svahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15552_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.ATV.0000193624.28251.83","article-title":"What does it take to make the perfect clot?","volume":"26","author":"Monroe","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15552_bb0015","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1006\/jmbi.1996.0264","article-title":"Conservation and variability in the structures of serine proteinases of the chymotrypsin family","volume":"258","author":"Lesk","year":"1996","journal-title":"J Mol Biol"},{"key":"10.1111\/jth.15552_bb0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbapap.2003.10.008","article-title":"Sequence and evolutionary analysis of the human trypsin subfamily of serine peptidases","volume":"1698","author":"Yousef","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/jth.15552_bb0025","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1172\/JCI109073","article-title":"Activation of human factor IX (Christmas factor)","volume":"61","author":"Di Scipio","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.15552_bb0030","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1021\/bi00286a009","article-title":"Redetermination of the rate\u2010limiting step in the activation of factor IX by factor XIa and by factor VIIa\/tissue factor. Explanation for different electrophoretic radioactivity profiles obtained on activation of 3H\u2010 and 125I\u2010labeled factor IX","volume":"22","author":"Bajaj","year":"1983","journal-title":"Biochemistry"},{"key":"10.1111\/jth.15552_bb0035","doi-asserted-by":"crossref","first-page":"11317","DOI":"10.1016\/S0021-9258(18)99165-9","article-title":"Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation","volume":"266","author":"Lawson","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15552_bb0040","doi-asserted-by":"crossref","first-page":"38200","DOI":"10.1074\/jbc.M112.376343","article-title":"A sequential mechanism for exosite\u2010mediated factor IX activation by factor XIa","volume":"287","author":"Geng","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15552_bb0045","first-page":"202","article-title":"Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ\u2010line transitions, transversions, and deletions in a human gene","volume":"47","author":"Koeberl","year":"1990","journal-title":"Am J Hum Genet"},{"key":"10.1111\/jth.15552_bb0050","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/jth.12276","article-title":"An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B","volume":"11","author":"Rallapalli","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15552_bb0055","doi-asserted-by":"crossref","first-page":"14884","DOI":"10.1074\/jbc.270.25.14884","article-title":"Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme","volume":"270","author":"Lenting","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15552_bb0060","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1515\/BC.2009.057","article-title":"Activation mechanisms of coagulation factor IX","volume":"390","author":"Z\u00f6gg","year":"2009","journal-title":"Biol Chem"},{"issue":"Suppl 1","key":"10.1111\/jth.15552_bb0065","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.thromres.2014.03.020","article-title":"The mechanism underlying activation of factor IX by factor XIa","volume":"133","author":"Gailani","year":"2014","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15552_bb0070","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2141.1991.tb04453.x","article-title":"Haemophilia B mutations in a complete Swedish population sample: a test of new strategy for the genetic counselling of diseases with high mutational heterogeneity","volume":"78","author":"Green","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15552_bb0075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1172\/JCI111700","article-title":"Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia\u2010B. Evidence for defects affecting the latent catalytic site","volume":"75","author":"Usharani","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.15552_bb0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1182\/blood.V74.1.193.193","article-title":"Molecular defects of factor IX Chicago\u20102 (Arg 145\u2013\u2013His) and prothrombin Madrid (Arg 271\u2013\u2013cys): arginine mutations that preclude zymogen activation","volume":"74","author":"Diuguid","year":"1989","journal-title":"Blood"},{"key":"10.1111\/jth.15552_bb0085","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2141.1989.tb04323.x","article-title":"Factor IX Cardiff: a variant factor IX protein that shows abnormal activation is caused by an arginine to cysteine substitution at position 145","volume":"72","author":"Liddell","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15552_bb0090","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.1995.tb03319.x","article-title":"Heteroduplex screening for molecular defects in factor IX genes from haemophilia B families","volume":"89","author":"Chen","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15552_bb0095","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1055\/s-0038-1653867","article-title":"Detection of ten new mutations by screening the gene encoding factor IX of Danish hemophilia B patients","volume":"73","author":"Nielsen","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15552_bb0100","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1055\/s-0037-1614851","article-title":"Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations","volume":"82","author":"Attali","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15552_bb0105","first-page":"635","article-title":"Molecular genotyping of the Italian cohort of patients with hemophilia B","volume":"90","author":"Belvini","year":"2005","journal-title":"Haematologica"},{"key":"10.1111\/jth.15552_bb0110","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1111\/jth.12410","article-title":"Origin of Swedish hemophilia B mutations","volume":"11","author":"Halld\u00e9n","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15552_bb0115","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1182\/blood.V73.3.718.718","article-title":"Molecular defect in factor IXHilo, a hemophilia Bm variant: Arg\u2013\u2013Gln at the carboxyterminal cleavage site of the activation peptide","volume":"73","author":"Huang","year":"1989","journal-title":"Blood"},{"key":"10.1111\/jth.15552_bb0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-0038-1651589","article-title":"Genetic basis and carrier detection of hemophilia B of Chinese origin","volume":"69","author":"Lin","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15552_bb0125","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood.V73.6.1540.1540","article-title":"Functional consequences of an arginine180 to glutamine mutation in factor IX Hilo","volume":"73","author":"Monroe","year":"1989","journal-title":"Blood"},{"key":"10.1111\/jth.15552_bb0130","doi-asserted-by":"crossref","first-page":"21257","DOI":"10.1016\/S0021-9258(19)30074-2","article-title":"Blood clotting factor IX BM Nagoya. Substitution of arginine 180 by tryptophan and its activation by alpha\u2010chymotrypsin and rat mast cell chymase","volume":"264","author":"Suehiro","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15552_bb0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2141.1991.tb04452.x","article-title":"Identification of a new haemophilia BM case produced by a mutation located at the carboxy terminal cleavage site of activation peptide","volume":"78","author":"Solera","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15552_bb0140","doi-asserted-by":"crossref","first-page":"721","DOI":"10.18388\/abp.1999_4144","article-title":"Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene","volume":"46","author":"Wulff","year":"1999","journal-title":"Acta Biochim Pol"},{"key":"10.1111\/jth.15552_bb0145","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1046\/j.1365-2141.2003.04141.x","article-title":"Molecular pathology of haemophilia B in Turkish patients: identification of a large deletion and 33 independent point mutations","volume":"120","author":"Onay","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15552_bb0150","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0140-6736(67)92179-4","article-title":"Haemophilia Bm: a new type of factor\u2010IX deficiency","volume":"1","author":"Hougie","year":"1967","journal-title":"Lancet"},{"key":"10.1111\/jth.15552_bb0155","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1182\/blood-2004-03-1028","article-title":"Novel hemophilia B mouse models exhibiting a range of mutations in the factor IX gene","volume":"104","author":"Sabatino","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.15552_bb0160","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1182\/blood-2010-06-290098","article-title":"Activation peptides prolong the murine plasma half\u2010life of human factor VII","volume":"117","author":"Johansson","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.15552_bb0165","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1160\/TH04-03-0201","article-title":"An important role for the activation peptide domain in controlling factor IX levels in the blood of haemophilia B mice","volume":"94","author":"Begbie","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15552_bb0170","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1182\/blood.V98.13.3600","article-title":"Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma\u2010derived factor IX concentrates","volume":"98","author":"Roth","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jth.15552_bb0175","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1182\/blood-2004-01-0138","article-title":"Creation of a mouse expressing defective human factor IX","volume":"104","author":"Jin","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.15552_bb0180","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1182\/blood.2018884015","article-title":"Dysfunctional endogenous FIX impairs prophylaxis in a mouse hemophilia B model","volume":"133","author":"Cooley","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1111\/jth.15552_bb0185","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/hae.14300","article-title":"The function of extravascular coagulation factor IX in haemostasis","volume":"27","author":"Mann","year":"2021","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15552_bb0190","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/blood.V58.3.625.625","article-title":"Labeled factor IX kinetics in patients with hemophilia\u2010B","volume":"58","author":"Smith","year":"1981","journal-title":"Blood"},{"key":"10.1111\/jth.15552_bb0195","doi-asserted-by":"crossref","first-page":"11068","DOI":"10.1073\/pnas.93.20.11068","article-title":"Identification of the endothelial cell binding site for factor IX","volume":"93","author":"Cheung","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.15552_bb0200","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1182\/blood-2016-01-696104","article-title":"Prophylactic efficacy of BeneFIX vs Alprolix in hemophilia B mice","volume":"128","author":"Cooley","year":"2016","journal-title":"Blood"},{"key":"10.1111\/jth.15552_bb0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12959-016-0104-2","article-title":"Extravascular FIX and coagulation","volume":"14","author":"Stafford","year":"2016","journal-title":"Thromb J"},{"key":"10.1111\/jth.15552_bb0210","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1538-7836.2011.04191.x","article-title":"Nomenclature of genetic variants in hemostasis","volume":"9","author":"Goodeve","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15552_bb0215","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/jth.14236","article-title":"The chaperone\u2010like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p. R294Q mutation","volume":"16","author":"Pignani","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15552_bb0220","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1182\/blood-2016-09-738641","article-title":"Specific factor IX mRNA and protein features favor drug\u2010induced readthrough over recurrent nonsense mutations","volume":"129","author":"Branchini","year":"2017","journal-title":"Blood"},{"key":"10.1111\/jth.15552_bb0225","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/humu.23404","article-title":"Secretion of wild\u2010type factor IX upon readthrough over F9 pre\u2010peptide nonsense mutations causing hemophilia B","volume":"39","author":"Ferrarese","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1111\/jth.15552_bb0230","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood-2009-09-199182","article-title":"Structure and function of factor XI","volume":"115","author":"Emsley","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.15552_bb0235","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/hae.12916","article-title":"Correlation between FIX genotype and pharmacokinetics of Nonacog alpha according to a multicentre Italian study","volume":"22","author":"Morfini","year":"2016","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15552_bb0240","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1160\/TH16-12-0942","article-title":"Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half\u2010life FIX concentrates","volume":"117","author":"Iorio","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15552_bb0245","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/jth.14473","article-title":"Functional polymorphisms in the LDLR and pharmacokinetics of factor VIII concentrates","volume":"17","author":"Lunghi","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15552_bb0250","series-title":"Pharmacokinetic and Pharmacodynamic data analysis, Concepts and Application","author":"Gabrielsson","year":"2007"},{"key":"10.1111\/jth.15552_bb0255","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1538-7836.2010.03757.x","article-title":"Comparative pharmacokinetics of plasma\u2010 and albumin\u2010free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age\u2010related differences and implications for dose tailoring","volume":"8","author":"Bj\u00f6rkman","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15552_bb0260","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1055\/s-0038-1649902","volume":"74","author":"Prowse","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15552_bb0265","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2516.2006.01401.x","article-title":"In vivo recovery of factor VIII and factor IX: intra\u2010 and interindividual variance in a clinical setting","volume":"13","author":"Bj\u00f6rkman","year":"2007","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15552_bb0270","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2141.1990.tb02652.x","article-title":"A mutation adjacent to the beta cleavage site of factor IX (valine 182 to leucine) results in mild haemophilia Bm","volume":"75","author":"Taylor","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15552_bb0275","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/oxfordjournals.jbchem.a122740","article-title":"Blood clotting factor IX Kashihara: amino acid substitution of valine\u2010182 by phenylalanine","volume":"105","author":"Sakai","year":"1989","journal-title":"J Biochem"},{"key":"10.1111\/jth.15552_bb0280","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1021\/bi00075a005","article-title":"Molecular defect in factor IX Tokyo: substitution of valine\u2010182 by alanine at position P2\u2019 in the second cleavage site by factor XIa resulting in impaired activation","volume":"32","author":"Maekawa","year":"1993","journal-title":"Biochemistry"},{"key":"10.1111\/jth.15552_bb0285","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2516.2008.01792.x","article-title":"Variability in bleeding phenotype in Amish carriers of haemophilia B with the 31008 C\u2013>T mutation","volume":"15","author":"Sharathkumar","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15552_bb0290","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/jth.15301","article-title":"Genetic analysis of carrier status in female members of Japanese hemophilia families","volume":"19","author":"Shinozawa","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15552_bb0295","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1182\/blood.V96.10.3459","article-title":"Activation of factor IX zymogen results in exposure of a binding site for low\u2010density lipoprotein receptor\u2010related protein","volume":"96","author":"Neels","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jth.15552_bb0300","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0140-6736(03)13405-8","article-title":"Haemophilias A and B","volume":"361","author":"Bolton\u2010Maggs","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/jth.15552_bb0305","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/bjh.13223","article-title":"Effect of age on factor IX levels in symptomatic carriers of haemophila B Leyden","volume":"169","author":"Hildyard","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15552_bb0310","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/jth.15259","article-title":"Safety, pharmacokinetics, and pharmacodynamics of a next\u2010generation subcutaneously administered coagulation factor IX variant, dalcinonacog alfa, in previously treated hemophilia B patients","volume":"19","author":"You","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15552_bb0315","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.17559","article-title":"Fusion of engineered albumin with factor IX Padua extends half\u2010life and improves coagulant activity","volume":"194","author":"Lombardi","year":"2021","journal-title":"Br J Haematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15552","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15552","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622027349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622027349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:34:07Z","timestamp":1761536047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622027349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1538783622027349"],"URL":"https:\/\/doi.org\/10.1111\/jth.15552","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}